At a Glance
| Ibogaine | 4-AcO-MiPT | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 15–22 mg/kg of body weight | 15–20 mg |
| Total Duration | 18.5–39 hrs | 2.8–6 hrs |
| Routes | oral | oral |
| Effects | 71 documented | 58 documented |
Ibogaine, a Psychedelic, and 4-AcO-MiPT, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 42 documented effects in common, with 29 effects unique to Ibogaine and 16 unique to 4-AcO-MiPT. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Ibogaine | 4-AcO-MiPT | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 15–22 mg/kg of body weight | 15–20 mg |
| Total Duration | 18.5–39 hrs | 2.8–6 hrs |
| Routes | oral | oral |
| Effects | 71 documented | 58 documented |
| Interaction |
| Low Risk & Synergy |
| Level | Ibogaine | 4-AcO-MiPT |
|---|---|---|
| Threshold | — mg/kg of body weight | 5 mg |
| Light | — mg/kg of body weight | 10–15 mg |
| Common | 15–22 mg/kg of body weight | 15–20 mg |
| Strong | — mg/kg of body weight | 20–35 mg |
| Heavy | — mg/kg of body weight | 35 mg |
Ibogaine
4-AcO-MiPT
Cross-tolerance exists; effects compound
No dangerous interactions recorded.
No dangerous interactions recorded.